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gen-presenting cells (APCs). We examined the effects of PrA on the
maturation and function of dendritic cells (DCs), a potent class
of APCs, and the downstream cell–cell and intracellular signaling
pathways mediating the immunosuppressive activity of PrA.
METHODS In this study, we examined the effect of PrA on DC
phenotype and compared the effects of native and PrA-treated DCs on
the proliferation and phenotype of T cells to elucidate the signaling
mechanisms of PrA-mediated immunosuppresion.
RESULTS PrA inhibited LPS-stimulated maturation of Wistar rat DCs
in vitro as reﬂected by reduced expression of costimulatory molecules
(CD80 and CD86) and reduced expression of TLR4 and NF- kB. PrA
also enhanced the release of IL-10 and decreased the release of IL-12
from DCs, but had no effect on the production of TGF-ß. In mixed
cultures, Wistar DCs pretreated with PrA impaired the proliferation of
Sprague Dawley (SD) rat T cells while promoting the expansion of SD
rat regulatory T cells (Tregs). Both oral PrA treatment and infusion of
PrA-pretreated Wistar DCs prolonged cardiac allograft survival and
expanded recipient Tregs. Donor spleen cells, but not spleen cells
from a third rat strain (DA), supported the expansion of recipient
Tregs and suppressed recipient T cell proliferation.
CONCLUSIONS We conclude that PrA triggers a tolerogenic state in
DCs that allows for the induction of alloantigen-speciﬁc Tregs and the
suppression of allograft rejection in vivo.
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Myocardial Genomic Gene Expression Proﬁle Analysis in Rats With Diabetic
Cardiomyopathy
Zhongwei Liu, Shuo Pan, Ying Lv, Na Zhao, Junkui Wang
Shaanxi Provincial People’s Hospital
OBJECTIVES Diabetic cardiomyopathy is considered one of the most
common cardiovascular complications of diabetes. However, the
exact molecular mechanisms are still obscure. This study was
designed to investigate differential expression of mRNA extracted
from myocytes of diabetic rats. Results from this study would provide
more and novel clues for further studies on diabetic cardiomyopathy.
METHODS Rats were divided into control group (Ctrl), diabetic car-
diomyopathy group (DbCM) and insulin treated group (ISN). Diabetes
in rats was induced by streptozotocin intraperitoneal injection. In ISN,
rats with diabetic cardiomyopathy received subcutaneous injection of
insulin (4-8U/day) for continuous 6 weeks. Cardiac function was
conﬁrmed by ventricular intubation hemodynamic examination. In
Ctrl and DbCM, rats received saline sc injection. Aglilent Whole
Genome Oligo Array was utilized to analyze mRNA differential
expressions in heart samples. Results of microarray were validated by
real-time PCR.
RESULTS 1510 mRNAs were found up-regulated while 1657 mRNAs
were found down-regulated in DbCM compared with Ctrl; 775 mRNAs
were found up- regulated while 614 mRNAs were found down-
regulated in ISN compared with DbCM. Notably, genes including
WDNM1 homolog, Sln (sarcolipin), Nppa (natriuretic peptide precursor
A), Mybphl (myosin binding protein H-like), Hamp (hepcidin antimi-
crobial peptide), Myl7 (myosin light chain 7), Upk1b (uroplakin 1B),
Msln (mesothelin) were found up-regulated in DbCM but corre-
spondingly down-regulated after insulin treatment in ISN. Pathway
analysis showed that pathways including PPAR, histidine metabolism,
calcium and PI3K-Akt signaling pathways were possibly involved in
DbCM. These changes were validated by RT-PCR.
CONCLUSIONS The mRNA differential expression proﬁling could
provide basis for further investigation of mechanisms of DbCM.
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Tetrahydroxystilbene Involve HSP-70 and SIRT1 in Preventing the
Progression of Diabetic Cardiomyopathy
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OBJECTIVES 2,3,5,4’-Tetrahydroxystilbene-2-O-b-D-glucoside (TSG)
from Polygoni multiﬂori has been demonstrated to possess a variety of
pharmacological activities, including antioxidant, anti-inﬂammatory
and anti-atherosclerotic effect. The present study was undertaken to
investigate the protective effect of TSG on modulating diabetic
cardiomyopathy and the mechanisms involved heat shock protein
(HSP-70) and longevity protein SIRT1 and also modulated apoptotic
proteins Bax and Bcl-2 in diabetic cardiomyopathy.METHODS A high-fat diet and low-dose streptozotocin administration
were used to induce type 2 diabetes in Wister rats. Diabetic rats were
treated with TSG for 16 weeks. Myocardial steatosis (detected by oil
red O staining and myocardial triglyceride and diacylglycerol (DAG)
contents assay), expression of protein HSP-70 and SIRT1, heart NAD(P)
H oxidase activity, oxidative stress markers were evaluated. Changes
in the expression of cytoprotective and apoptotic proteins in the heart
of rats were also examined.
RESULTS Administration of TSG did not affect plasma glucose and
insulin levels or body weights in STZ-induced diabetic rats, but
normalized myocardial steatosis, expression of HSP-70 and SIRT1-
protein, NAD(P)H oxidase activity and oxidative stress markers, all of
which were signiﬁcantly increased in diabetic hearts. TSG also
modulated apoptotic proteins Bax and Bcl-2 in diabetic heart.
CONCLUSIONS These ﬁndings indicate that the protective mechanisms
of TSG on diabetic cardiomyopathy are involved in the alleviation of
oxidative stress injury and regulating apoptosis, partially via activation
of cyto-protective protein HSP-70 and longevity protein SIRT1.
This work was supported by the Foundation from Natural Science
Foundation of Hubei Province of China 2011CDB315, and Health and
Family Planning Commission of Hubei Province (WJ2015Z122).
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Human Umbilical Cord Blood Derived Mesenchymal Stem Cells Improve
Cardiac Function in cTnTR141w Transgenic Mouse of Dilated
Cardiomyopathy
Xuhe Gong, Guogan Wang
Fuwai Hospital, National Center for Cardiovascular Diseases
OBJECTIVES Cell transplantation is a promising strategy in regener-
ative medicine, the beneﬁcial effects of bone marrow mesenchymal
stem cells (BM-MSCs) in the heart diseases are widely reported,
however, MSCs in these studies are animal autogenous derived, data
are still scarce on MSCs from human umbilical cord blood(UCB-MSCs).
We investigated whether the intramyocardial xenogeneic adminis-
tration of UCB-MSCs offers beneﬁt in preserving heart function in
cTnTR141W transgenic mouse model of dilated cardiomyopathy (DCM).
METHODS Cultured UCB-MSCs, which were identiﬁed by mor-
phology, differentiation and cell surface markers, were transplanted
into cTnTR141W transgenic mouse to examine apoptosis, ﬁbrosis, vas-
culogenesis and their associated Akt pathway. We also determined
levels of VEGF and IGF-1, growth factors required for their differen-
tiation into cardiac myocytes, which also contributes in cardiac
regeneration and improved heart function. Moreover, medium pro-
duced by MSCs preconditioned under normoxia or hypoxia was
collected for subsequent in vitro assays.
RESULTS MSCs signiﬁcantly decreased chamber dilation and con-
tractile dysfunction in cTnTR141W mouse. MSCs transplanted hearts
showed a signiﬁcant decrease in cardiac apoptosis and their regula-
tion with Akt pathway. Cardiac ﬁbrosis and cytoplasmic vacuolization
in the MSCs group was signiﬁcantly lower. Importantly, the levels of
VEGF and IGF-1 were increased in MSCs transplanted hearts, sug-
gesting endogenous cardiac regeneration. In vitro, the MSC-condi-
tioned medium displayed anti-apoptotic activity in h9c2
cardiomyocytes subjected to hypoxia, further conﬁrmed the paracrine
effects of MSCs.
CONCLUSIONS UCB-MSCs preserve cardiac function after intra-
myocardial transplantation in a DCM mouse model, which may be
associated with inhibition of cellular apoptosis, inﬂammatory, up-
regulated expressions of Akt, VEGF, IGF-1 and enhanced angiogenesis.
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Exploration of a Method to Establish Rabbit Model of Nonsustained
Ventricular Tachycardia Cardiomyopathy
Xianghui Zeng,1 Xiaohua Zhou,1 Xiang Sun,1 Jing Ling,1 Yanyun Qing,1
Yi Zhang2
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OBJECTIVES To explore a method to establish a rabbit model of
nonsustained ventricular tachycardia cardiomyopathy.
METHODS Fifteen New Zealand rabbits were used in this study. The
right ventricle was stimulated with mapping electrode line to create
nonsustained ventricular tachycardia by minimally invasive venous
technique without X-ray use, using a 10 polar cap of sinus electrode
inserted through modiﬁed 5F radial artery sheath and the right
anterior vena cava to the right ventricle, connecting the programming
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and then to pace the right ventricle.
RESULTS After one week of right ventricular pacing, cardiac ultrasound
examination conﬁrmed the left ventricular end diastolic diameter
enlargement, reduction of left ventricular ejection fraction, increased
serum BNP and MMP-9, and decreased TIMP-1. Pathology of HE staining
showed myocardial structural derangement and interstitial inﬂamma-
tory cell inﬁltration. Electron microscopy revealed mitochondrial
swelling, dissolution, or even lysis and destruction, fuzzy Z line and
unclear intercalated discs. Three weeks later, the heart color, serum
BNP, MMP-9, TIMP-1, EF, FS in the rabbits recovered to former levels.
CONCLUSIONS Conclusions It is a simple and practical method to
establish an animal model of tachycardiomyopathy by stimulating
animal’s right ventricle with mapping electrode line to create non-
sustained ventricular tachycardia under minimally invasive, venous
technique without X-ray radiation.
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Correlation Between the BDNF Val66Met Polymorphisms and Metabolic
Risks in Long-Lived Zhuang Population
Junhua Peng, Peng Sun, Chengwu Liu, Shangling Pan
Department of Pathophysiology, Guangxi Medical University, Nanning,
Guangxi, China
OBJECTIVES We aim to evaluate the possible association between
BDNF Val66Met polymorphism and common metabolic risks including
BMI, fasting blood glucose (FBG) and lipid levels in a longevous
population dwelling in Guangxi Hongshui River basin.
METHODS BDNF Val66Met was genotyped by ARMS-PCR technique
for 487 Zhuang long-lived inhabitants (aged  90, long-lived group,
LG), 593 offspring (age 60-77, offspring group, OG) and 582 matched
healthy controls (aged 60-75, control group, CG) in Hongshui River
Basin. Impacts of genotypes on metabolic risks were then evaluated.
RESULTS No signiﬁcant difference was noted on the distribution of
genotypic and allelic frequencies of BDNF Val66Met among the three
groups (all P > 0.05), regardless of sex; however, AA genotype was
dramatically higher in females than in males in the CG. The HDL-C
level of A genotype (GA/AA) carriers was signiﬁcantly lower than was
non-A genotype (GG) carriers in the overall population and the CG
(P ¼0.009 and 0.006, respectively), which remained in females, hy-
perglycemic subgroup and normolipidemic subgroup of CG through
stratiﬁcation of sex, BMI, glucose and lipid status. In addition, A ge-
notype carriers, with a higher systolic blood pressure, have 1.63 folds
higher risk than non-A carriers to become overweight in CG (95% CI :
1.05～2.55). Multiple regression analysis showed that the TC level of
LG was negatively correlated with BDNF Val66Met genotype.
CONCLUSIONS BDNF 66Met may lower the serum HDL-C level and
lead to overweight in the general population in Hongshui River area
but has less impact on the long-lived population and their offspring.
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Endoplasmic Reticulum Stress in Neonatal Mouse Cardiomyocytes
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OBJECTIVES Endoplasmic reticulum (ER) stress has become an
important therapeutic target for myocardial ischemia reperfusion (I/R)
injury. It has been reported that lycopene exhibits great pharmaco-
logical effect in alleviating myocardial I/R-injury, but whether it
attenuates ER stress remains to be elucidated. The purpose of this
study was to explore the potential protective beneﬁts of lycopene
against ER stress induced by hypoxia/reoxygenation in cultured
neonatal mouse cardiomyocytes.
METHODS Primary cultured neonatal C57BL/6 cardiomyocytes were
used to establish H/R model and divided to control, lycopene, H/R(4 h
hypoxia followed by 6 h reoxgenation) and lycopeneþH/R group (the
cardiomyocytes were pretreatment with 5mmol/L lycopene for 4 h
before H/R treatment). TUNEL assay was used to assess car-
diomyocytes apoptosis. Western blotting was used to evaluate the
expression of cleaved caspase-3, the level of phosphorylated eIF2a, a
downstream target of the PERK pathway and the expression of CHOP,
an ER stress-related apoptotic maker. The expression of GRP78 mRNAand level of the sliced Xbp-1 mRNA, a downstream target of the IRE1
pathway, were determined by Real-time PCR.
RESULTS The rate of TUNEL-positive cells signiﬁcantly increased to
25.622.61% and that of control and lycopene group were respectively
4.871.54% and 4.911.63% (P ＜0.01). After pretreatment with
lycopene, the rate decreased to 18.182.18% (P ＜0.05). Representa-
tive western blotting analysis and Quantitation of the Western blot-
ting by densitometric scanning showed approximately a 1.89-fold
increase in cleaved caspase-3 level (P ＜0.01), 1.84-fold increase in p-
eIF2a (P ＜0.05) and 1.98-fold increase in CHOP expression (P ＜0.01)
compared with the control group after H/R treatment. The cleaved
caspase-3 level decreased to 1.36-fold of normal levels (P ＜0.05), the
level of phosphorylated eIF2a reduced to 1.47-fold of normal levels (P
＜0.05) and the CHOP expression decreased to 1.54-fold of control
levels (P＜0.05) with lycopene pretreatment. Data from real-time PCR
displayed that H/R treatment induced a more than 4-fold increase in
the expression of GRP78 mRNA (P ＜0.01). Conversely, the mRNA
expression of GRP78 was signiﬁcantly attenuated to approximately 2-
fold of normal levels with 5 mM lycopene pretreatment (P ＜0.01), but
not completely come back the control levels. The level of the sliced
Xbp-1 mRNA had a 2.23-fold increase in H/R-treated cardiomyocytes
compared to control groups (P ＜0.01), in contrast, the level of the
sliced Xbp-1 mRNA was markedly downregulated to 1.20-fold of
control levels with 5 mM lycopene pretreatment (P ＜0.01), but not
completely come back the normal levels.
CONCLUSIONS The present study demonstrated that lycopene pro-
tects primary cultured neonatal mouse cardiomyocytes against H/R
injury by inhibiting the activation of the PERK and the IRE1 pathway
of the ER stress, the protective effect of lycopene on cardiomyocytes
highlights the therapeutic potential of plant-derived antioxidants
against I/R-injury.
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Vagal Nerve Stimulation Reverses Cardiac Dysfunction and Subcellular
Calcium Handling in Heart Failure Rats After Myocardial Infarction
Yunhe Zhang, Ao Chen, Lei Song, Min Li, Ben He, Yingmin Chen
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OBJECTIVES Vagal nerve stimulation (VNS) as a non-pharmacological
approach to retrieve the autonomic balance, has showed beneﬁcial
therapeutic effects for chronic heart failure (CHF). Moreover, calcium
cycling is critical in cardiac excitation-contraction coupling (ECC) and
participates in the antiarrhythmic effects of VNS. Taken together, we
hypothesized that VNS could improve the calcium handling properties
which might be underlying mechanisms of VNS for heart failure
treatment.
METHODS In this study, 32 SD rats were divided into three groups as
Control (sham operated), CHF-SS (CHF rats with sham stimulation)
and CHF-VNS (CHF rats with VNS). Cardiac function was evaluated by
echocardiography while the structural remodeling was assessed by HE
and Masson staining. ELISA was used to detect the plasma BNP,
norepinephrine and angiotensin II concentrations. The proteins and
mRNAs expression of sarcoplasmic reticulum Ca2þ ATPase (SER-
CA2a), phospholamban (PLB), ryanodine receptor 2 (RyR2), Naþ–Ca2þ
exchanger 1 (NCX1) were analyzed by Western blot and RT-PCR.
RESULTS Compared with CHF-SS rats, rats from CHF-VNS group
received 8 weeks of VNS showed signiﬁcantly improved left ventricular
ejection fraction (LVEF, P¼0.001) and less myocardial interstitial
collagen. The elevated plasma concentrations of BNP, norepinephrine
and Ang II in CHF rats were partially restored by VNS. After VNS, the rats
in CHF-VNS group exhibited statistically signiﬁcant higher cardiac SER-
CA2a protein and mRNA contents than CHF-SS group. RyR2 and
depressed PLB expressions were unaffected between rats with or without
VNS, whereas NCX1 expression was signiﬁcant lower in CHF-VNS group.
CONCLUSIONS The results suggest that the improvement of cardiac
performance by VNS is accompanied with reversal of changes in cal-
cium handling properties including SERCA2a, PLB and NCX1 which
may be underlying mechanisms of VNS for heart failure therapy.
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miR-433 Controls Cardiac Fibrosis
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OBJECTIVES Cardiac ﬁbrosis, a result of multiple injurious insults in
heart, is a ﬁnal common manifestation of chronic heart diseases and
